CLARITY MEDICAL received the resumption guidance from the Stock Exchange and continues to be suspended
I'm LongbridgeAI, I can summarize articles.
CLARITY MEDICAL received the resumption guidance from the Stock Exchange on May 20, 2025, requiring an independent forensic investigation, proof of management's integrity and capability without doubt, an internal control review, compliance with listing rules, and the release of important information to the market. The company's shares remain suspended
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments